The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. 89bio Inc shares valued at $91,208 were sold by Le-Nguyen Quoc on Apr 15 ’25. At $5.95 per share, Le-Nguyen Quoc sold 15,329 shares. The insider’s holdings dropped to 328,323 shares worth approximately $3.28 million following the completion of this transaction.
Also, QUOC LE-NGUYEN purchased 15,329 shares, netting a total of over 91,171 in proceeds.
Before that, RA CAPITAL MANAGEMENT, L.P. had added 5,714,285 shares to its account. In a trade valued at $49,999,994, the Director bought 89bio Inc shares for $8.75 each. Upon closing the transaction, the insider’s holdings increased to 5,714,285 shares, worth approximately $195.54 million.
As published in their initiating research note from Goldman on March 14, 2025, 89bio Inc [ETNB] has been a Neutral and the price target has been revised to $11. Analysts at Citigroup started covering the stock with ‘”a Buy”‘ outlook in a report released in mid March. As of February 04, 2025, Wolfe Research has initiated its “an Outperform” rating for ETNB.
Analyzing ETNB Stock Performance
On last trading session,, 89bio Inc [NASDAQ: ETNB] rose 0.60% to $10.00. During the last five days, there has been a drop of approximately -0.40%. Over the course of the year, 89bio Inc shares have jumped approximately 27.88%. Shares of the company reached a 52-week high of $11.84 on 02/05/25 and a 52-week low of $4.16 on 04/09/25.
Support And Resistance Levels for 89bio Inc (ETNB)
According to the 24-hour chart, there is a support level at 9.74, which, if violated, would cause prices to drop to 9.49. In the upper region, resistance lies at 10.17. The next price resistance is at 10.35. RSI (Relative Strength Index) is 57.01 on the 14-day chart, showing neutral technical sentiment.
Which companies own the most shares of 89bio Inc (ETNB)?
In terms of 89bio Inc share price expectations, FactSet research, analysts set an average price target of 25 in the next 12 months, up nearly 151.51% from the previous closing price of $9.94. Analysts anticipate 89bio Inc stock to reach 29 by 2025, with the lowest price target being 12. In spite of this, 8 analysts ranked 89bio Inc stock as Buy at the end of 2025. On January 12, 2024, RBC Capital Mkts assigned a price target of “a Sector perform” to the stock and downgraded coverage with a $15.
